Bg pattern

GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

GalliaPharm 1.48GBq Radionuclide Generator

Solution of gallium chloride (68Ga)

Read all of this leaflet carefully before you receive this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your nuclear medicine specialist who will be supervising the procedure.
  • If you experience any side effects, talk to your nuclear medicine specialist, even if they are not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is GalliaPharm and what is it used for
  2. What you need to know before you start using the gallium chloride (68Ga) solution obtained with GalliaPharm
  3. How to use the gallium chloride (68Ga) solution obtained with GalliaPharm
  4. Possible side effects
  5. Storage of GalliaPharm
  6. Package Contents and Further Information

1. What is GalliaPharm and what is it used for

GalliaPharm is a germanium (68Ge)/gallium (68Ga) radionuclide generator, a device used to obtain a solution of gallium chloride (68Ga). Gallium chloride (68Ga) is a substance whose handling is the responsibility of specialized physicians (nuclear medicine specialists) and pharmacists with the necessary training to work with radioactive materials. Gallium chloride (68Ga) is not intended for direct use in patients, but is used for radiolabeling, a technique in which a substance is labeled (radiolabeled) with a radioactive compound, in this case, 68Ga.

Only medications that have been specifically developed and approved for radiolabeling with 68Ga are subjected to the radiolabeling procedure with gallium chloride (68Ga). These radiolabeled medications can recognize and bind to particular types of body cells and carry the radioactive 68Ga to these body cells. The small amount of radioactivity present in the radiolabeled medication can be detected from outside the body using special cameras. This can help your doctor with diagnosis. For more information, see the package leaflet of the medication to be radiolabeled with gallium chloride (68Ga).

Your nuclear medicine specialist will explain the type of examination to be performed in more detail.

The use of a medication labeled with 68Ga involves receiving a small amount of radioactivity. Your doctor and nuclear medicine specialist have considered that the clinical benefit you will gain from the procedure with the medication labeled with 68Ga outweighs the risk of radiation.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start using the gallium chloride (68Ga) solution obtained with GalliaPharm

The gallium chloride (68Ga) solution obtained with GalliaPharm must not be administered

  • if you are allergic to gallium chloride (68Ga) or to any of the other components of this medication (listed in section 6).

If you are using a medication labeled with 68Ga, you should read the information about contraindications included in the package leaflet of the medication to be radiolabeled.

Warnings and Precautions

For information on special warnings and precautions for the use of medications labeled with 68Ga, see the package leaflet of the medication to be radiolabeled.

Children and Adolescents

Tell your nuclear medicine specialist if you or your child are under 18 years old.

Other Medications and the Gallium Chloride (68Ga) Solution

Tell your nuclear medicine specialist if you are taking, have recently taken, or might take any other medication, as some medications may interfere with the interpretation of images by your doctor.

It is not known if the gallium chloride (68Ga) solution can interact with other medications, as specific studies have not been conducted. You will not receive an injection of gallium chloride (68Ga), but a medication that has been combined (radiolabeled) with a solution of gallium chloride (68Ga).

For information on other medications in combination with the use of medications labeled with 68Ga, see the package leaflet of the radiolabeled medication.

Pregnancy, Breast-feeding, and Fertility

If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your nuclear medicine specialist for advice before you are given medications labeled with 68Ga.

If there is any possibility that you may be pregnant, if you have missed a period, or if you are breast-feeding, inform your nuclear medicine specialist before administration of medications labeled with 68Ga.

In case of doubt, it is important that you consult your nuclear medicine specialist who will be supervising the procedure.

If you are pregnant

Your nuclear medicine specialist will only give you this medication labeled with 68Ga during pregnancy if the expected benefit outweighs the risk.

If you are breast-feeding

You will be asked to stop breast-feeding. Ask your nuclear medicine specialist when you can restart breast-feeding.

Driving and Using Machines

There may be effects on the ability to drive and use machines due to the use of medications labeled with 68Ga. Read the package leaflets of those medications carefully.

3. How to use the gallium chloride (68Ga) solution obtained with GalliaPharm

The use, handling, and disposal of radiopharmaceuticals are subject to very strict rules. GalliaPharm will only be used in special controlled areas. The production of the gallium chloride (68Ga) solution, as well as the radiolabeling of a specific carrier medication and the administration of a medication labeled with 68Ga, will be the exclusive responsibility of properly trained and qualified personnel to use it safely. These personnel will take special care in the safe use of this medication and will inform you of their actions.

Your nuclear medicine specialist who will be supervising the procedure will decide on the amount of medication labeled with 68Ga to be used in your case. This will be the minimum amount necessary to obtain the desired information.

Administration of the Gallium Chloride (68Ga) Solution and Performance of the Procedure

You will not be given the gallium chloride (68Ga) solution, but another medication that has been combined (radiolabeled) with a solution of gallium chloride (68Ga).

Duration of the Procedure

Your nuclear medicine specialist will inform you about the usual duration of the procedure with the medication labeled with 68Ga. For more information, see the package leaflet of the radiolabeled medication.

After Administration of the Medication Labeled with Gallium Chloride (68Ga) Solution

Your nuclear medicine specialist will inform you if you need to take special precautions after you have been given the medication labeled with 68Ga. Ask your nuclear medicine specialist if you have any doubts.

If You Have Been Given More Medication Labeled with Gallium Chloride (68Ga) Solution Than You Should, or if You Have Received a Direct Injection of Gallium Chloride (68Ga) Solution by Accident

It is unlikely that an overdose or accidental direct injection of a gallium chloride (68Ga) solution will occur, because you will only receive the medication labeled with 68Ga under the precise control of your nuclear medicine specialist who is supervising the procedure. Nevertheless, in case of overdose or accidental direct injection, you will receive appropriate care.

If you have any further questions on the use of this medication, ask your nuclear medicine specialist who is supervising the procedure.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medications, the medication labeled with 68Ga can cause side effects, although not everybody gets them.

After administration of the medication labeled with 68Ga, you will be given low amounts of ionizing radiation with the lowest risk of cancer and congenital anomalies.

For more information on possible side effects, see the package leaflet of the radiolabeled medication.

Reporting of Side Effects

If you experience any side effects, talk to your nuclear medicine specialist, even if they are not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of GalliaPharm

You will not need to store this medication. This medication is stored under the responsibility of your specialist in suitable premises. The storage of radiopharmaceuticals will be carried out in accordance with national regulations on radioactive materials.

This information is intended for healthcare professionals only.

The radionuclide generator must not be used after the expiry date stated on the container after «EXP».

Do not dismantle the box.

The gallium chloride (68Ga) solution obtained with GalliaPharm must be used immediately.

6. Package Contents and Further Information

Composition of GalliaPharm:

  • The active substances are germanium (68Ge) and gallium (68Ga) chloride dissolved in sterile ultrapure hydrochloric acid at a concentration of 0.1 mol/l. The germanium (68Ge) is irreversibly trapped within the radionuclide generator and decays into its daughter nuclide (68Ga), which is obtained from the generator as gallium (68Ga) chloride.
  • The other components are:

Titanium dioxide (matrix)

Sterile ultrapure hydrochloric acid at a concentration of 0.1 mol/l (eluate solution)

A radionuclide generator is supplied with:

  1. 1 PP container containing the eluate, 250 ml of sterile ultrapure hydrochloric acid at a concentration of 0.1 mol/l (including a separate hanger for PP vials; PP: polypropylene)
  2. 1 ventilated puncture device (ABS: acrylonitrile butadiene styrene/PE: polyethylene)
  3. 2 1/16” male LUER adapters (PEEK)
  4. 2 tubes (60 cm) (PEEK)
  5. 1 tube (40 cm) (PEEK)
  6. 1 tube (20 cm) (PEEK)
  7. 3 1/16” 10-32 Fingertight connectors (PEEK)
  8. 1 1/16” M6 Fingertight connector (PEEK)
  9. 1 key box (TPX: polymethylpentene/HDPE: high-density polyethylene)
  10. 1 male LUER union (PP)

Appearance and Package Contents

You will not receive or handle this medication.

Marketing Authorization Holder and Manufacturer

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Str. 10

13125 Berlin

Germany

Date of Last Revision of this Leaflet:

Other Sources of Information

Detailed information on this medication is available on the European Medicines Agency website: http://www.ema.europa.eu.

On the European Medicines Agency website, this leaflet can be found in all languages of the European Union/European Economic Area.

--------------------------------------------------------------------------------------------------------------

This information is intended for healthcare professionals only:

The full summary of product characteristics of GalliaPharm is provided in a separate document in the product packaging, with the aim of providing healthcare professionals with additional scientific and practical information on the administration and use of this radiopharmaceutical.

See the summary of product characteristics or package leaflet.

Online doctors for GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR

Discuss questions about GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR?
GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR?
GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR is manufactured by Eckert & Ziegler Radiopharma Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to GALLIAPHARM 1.48 GBq RADIONUCLIDE GENERATOR?
Other medicines with the same active substance () include GALLIAPHARM 0.74 - 1.85 GBq RADIONUCLIDE GENERATOR, NORCOLESTEROL IODINATED (131 I) CIS BIO INTERNATIONAL 7.5-15 MBq/ml INJECTABLE SOLUTION, ADREVIEW 74 MBq/ml INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media